ERBB2 and neoplasm: In the current study, these in vitro findings were confirmed in an in vivo context, where it was shown that lapatinib alone or a combination of lapatinib and 5-FU potently inhibited the tumor growth of HER2-amplified N87 GC cell-bearing xenografts (Fig. 1).